Instituto Nacional de Cardiologia
Mexico City, Mexico
NCT Number: NCT01532167
The purpose of this study is to demonstrate that [18F]FDG PET is a a better method than clinical and laboratory values for the identification and assessment of inflammatory activity in patients with Takayasu Arteritis (TA), allowing long-term follow-up with a precise evaluation of response to therapy.
Looking for future studies?
Notify MeAll sexes
Observational
Mexico City, Mexico
Inflammatory activity and fibrosis are the main causes of morbidity and mortality in patients with Takayasu arteritis. The investigators objective is to determine the utility of using 18F-FDG PET in the basal evaluation and follow-up of patients and compare the results with Dabague's clinical score.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Instituto Nacional de Cardiologia Ignacio Chavez
Other
Impact and Utility of Positron Emission Tomography (PET) for the Assessment of Inflammatory Activity Arteritis Versus Clinical Score and Laboratory Values in Takayasu Arteritis: a Cohort Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07686991
Aortic Arch Syndromes, Aortic Diseases
Paris, France
View Trial DetailsNCT07500467
Aortic Arch Syndromes, Aortic Diseases
Beijing, Beijing Municipality, China
View Trial DetailsNCT03482479
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Aortic Arch Syndromes
Boston, Massachusetts, United States
View Trial DetailsNCT07149805
Aortic Arch Syndromes, Aortic Diseases
View Trial Details